Apogee Therapeutics, Inc. (APGE) Earnings
Apogee Therapeutics, Inc. is expected to report next earnings on November 9, 2026 (in NaN days), with a consensus EPS estimate of $-1.14. APGE has beaten EPS estimates in 2 of its last 6 reported quarters (average surprise +0.3% over the last four).
Next earnings
Nov 9, 2026in NaN days
EPS est $-1.14 · Revenue est $10M
Track record
Beat EPS in 2 of 6 quarters
Avg surprise +0.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 10, 2026 | $-1.07 | $-1.14 | -6.5% | — | — |
| May 11, 2026 | $-1.12 | $-1.06 | +5.4% | — | — |
| Mar 3, 2025 | $-0.94 | $-1.19 | -26.6% | — | — |
| Mar 5, 2024 | $-0.45 | $-0.32 | +28.9% | — | — |
| Nov 13, 2023 | $-0.38 | $-0.51 | -34.2% | — | — |
| Jul 17, 2023 | $-1.70 | $-3.78 | -122.4% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.